The orphan receptor tyrosine kinase Tie-1 is expressed in endothelial cells and is essential for vascular development. Nothing is known about the signaling pathways utilized by this receptor. In this study we have used chimeric receptors composed of the TrkA ectodomain fused to the transmembrane and intracellular domains of Tie-1, or the related receptor Tie-2, to examine Tie-1 signaling capacity. In contrast to TrkA/Tie-2, the Tie-1 chimera was unable to phosphorylate cellular proteins or undergo autophosphorylation. Consistent with this Tie-1 exhibited negligible kinase activity. Co-immunoprecipitation analysis revealed Tie-1 was present in endothelial cells bound to Tie-2. Full-length Tie-1 and truncated receptor, formed by regulated endoproteolytic cleavage, were found to complex with Tie-2. Association was mediated by the intracellular domains of the receptors and did not require Tie-1 to be membranelocalized. Tie-
The receptor kinases Tie-1 and Tie-2 are expressed predominantly in endothelial cells and are essential for developmental vascularization where they appear to have roles in promoting microvessel maturation and stability (1) . Targeted disruption of the Tie-1 gene in mice results in a lethal phenotype characterized by extensive hemorrhage and defective microvessel integrity (2) (3) (4) . Transgenic mice deficient in Tie-2 have defects in vessel sprouting and remodeling and die at around mid-gestation (3, 4) . Close examination of microvessels of Tie null mice suggest that the two receptors may have opposing actions in controlling intussusceptive capillary growth (4) . Structurally, Tie-1 and -2 share a number of features and constitute a distinct subfamily of receptor tyrosine kinases (5) . The extracellular domains of Tie-1 and -2 comprise two immunoglobulinlike domains separated by three epidermal growth factor motifs and followed by three fibronectin III-like repeats (6 -11) .
The intracellular domains of the receptors each contain a tyrosine kinase domain interrupted by a kinase insert region. Overall sequence identity between Tie-1 and -2 at the amino acid level is 44% and in the intracellular domains increases to 76%.
A number of ligands, designated the angiopoietins, have been identified for Tie-2 (12) (13) (14) (15) (16) . Angiopoietin-1 (Ang-1) 1 and angiopoietin-2 (Ang-2) are the best characterized of these. Binding of Ang-1 induces tyrosine phosphorylation of Tie-2 and activation of its signaling pathways, whereas Ang-2 has been reported to antagonize these effects in endothelial cells (12, 14) . Ang-1 activation of Tie-2 inhibits apoptosis (17) (18) (19) (20) and promotes sprouting (21) (22) (23) in vascular endothelial cells. In vivo Ang-1 promotes blood vessel maturation during angiogenesis and inhibits leakage from adult microvessels (24, 25) . Overall, the known effects of positive signaling through Tie-2 are consistent with this receptor promoting microvessel stability. Binding of Ang-1 to Tie-2 stimulates tyrosine phosphorylation of the receptor and recruitment of signaling intermediates. Several signaling proteins have been shown to bind Tie-2, including the p85 subunit of phosphatidylinositol 3-kinase, the tyrosine phosphatase SHP2, and adaptor proteins Grb2 and downstream of kinase-related (26 -28) . Ang-1-induced recruitment of p85 is associated with increased activity of phosphatidylinositol 3-kinase and Akt and up-regulation of survivin leading to an inhibition of endothelial cell apoptosis (18, 19) .
In contrast to Tie-2, nothing is known about the cellular functions controlled by Tie-1 or the signaling pathways utilized by this receptor. In addition, ligands for Tie-1 have yet to be identified. Here we have examined the signaling potential of Tie-1 using a chimeric receptor approach. We find the receptor incapable of autophosphorylation or inducing tyrosine phosphorylation of cellular proteins in endothelial cells. In accord with this baculovirus-expressed Tie-1 exhibits negligible tyrosine kinase activity. However, we also find that in endothelial cells Tie-1 physically associates with Tie-2. A number of previous reports have speculated that Tie-1 may have direct roles in Tie-2 signaling (14, 22, 29) . The present findings strengthen this possibility and provide potential mechanisms whereby this could occur. The existence of a pre-formed Tie-1⅐Tie-2 complex suggests direct functional cooperation between these two receptors in control of endothelial behavior and blood vessel development.
EXPERIMENTAL PROCEDURES
Materials-Antibodies directed against the extracellular domains of Tie-1 and -2 were obtained from R & D Systems Ltd., and those against the carboxyl-terminal sequences of Tie-1 and Tie-2 were from Santa Cruz Biotechnology Inc. Anti-TrkA monoclonal antibody was from Zymed Laboratories Inc. The monoclonal antiphosphotyrosine antibody was from BD Transduction Laboratories. cDNA corresponding to human full-length Tie-1 and -2 and the Tie-1 endodomain comprising the entire transmembrane and intracellular domains of Tie-1 (nucleotides 2274 -3440) were obtained by reverse transcription and polymerase chain reaction. These clones were confirmed by DNA sequencing. cDNA encoding TrkA was a kind gift from Dr. J. Tavare (University of Bristol). A HindIII restriction site was engineered at residue 408 of TrkA by site-directed mutagenesis (Stratagene) and was used to subclone the TrkA ectodomain in-frame with the transmembrane and intracellular domains of Tie-1 and Tie-2. For expression of intracellular sequences, Tie-1 was subcloned into the pSecTag expression vector (Invitrogen) in-frame with the leader sequence. To incorporate an amino-terminal FLAG epitope tag, the Tie-1 endodomain was subcloned into the pFLAG vector (Sigma). Deleted forms of Tie-1 endodomain are detailed in Fig.  3 and were generated by using existing restriction sites. Sequences were confirmed using a 373A ABI automated DNA sequencer. Nerve growth factor (NGF) and Complete TM protease inhibitor were from Roche Molecular Biochemicals. All other reagents were obtained from Sigma or sources described previously (30) .
Cell Culture and Transfection-Endothelial cells were isolated and cultured as described previously (30, 31) . Human umbilical vein endothelial cells (HUVEC) were maintained in Medium 199 containing 100 g/ml streptomycin, 100 units/ml penicillin, 20% fetal calf serum, 5 units/ml heparin, and 100 g/ml endothelial cell growth supplement. Bovine aortic endothelial cells (BAEC) were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum supplemented with 100 g/ml streptomycin and 100 units/ml penicillin. Transfections of BAEC were performed using Superfect TM (Qiagen Ltd.) according to the manufacturer's instructions.
Kinase Assay-cDNA encoding the intracellular domains of Tie-1 (amino acids 785-1138) and Tie-2 (amino acids 771-1124) were cloned into the BamHI-EcoRI sites of baculovirus transfer plasmid pFastBac1 (Life Technologies, Inc.). Recombinant baculovirus was prepared using the Bac-to-Bac expression system (Life Technologies, Inc.) and used to infect 2 ϫ 10 6 /ml insect cells at multiplicity of infection of 1. Forty eight hours after infection cells were lysed in HNTG buffer (20 mM HEPES, pH 7.4; 150 mM NaCl; 10% glycerol; 1% Triton X-100; 1.5 mM MgCl 2 ; 1 mM EGTA; 1 mM phenylmethylsulfonyl fluoride). Lysates were diluted with HNTG buffer to a final concentration corresponding to 10 7 cells/ml, cleared by centrifugation, and used as required or aliquoted and snapfrozen at Ϫ80 C. Kinase assays were performed in enzyme-linked immunosorbent assay plates coated with the substrate poly(Glu, Ala, Tyr) 6:3:1. Diluted lysates containing 10 mM MnCl 2 , 5 M ATP, 50 mM HEPES, pH 7.4, 0.1 mM sodium orthovanadate, 0.1% Triton X-100, and 25 mM dithiothreitol were incubated in the wells at 21 C for 60 min, and tyrosine phosphorylation of substrate was measured by enzymelinked immunosorbent assay using the 4G10 anti-phosphotyrosine antibody (Upstate Biotechnology, Inc.). Optical density of the wells was measured at 405 nm wavelength (Molecular Dynamics).
Immunoprecipitation and Blotting-Endothelial cells were washed in PBS and lysed at 4°C in 0.5 ml of lysis buffer (50 mM Tris, pH 7.4, containing 50 mM NaCl, 1% Triton X-100, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 1 mM EGTA) and Complete TM protease inhibitor mixture. For examination of tyrosine phosphorylation in total cell extracts, aliquots of lysate were diluted with Laemmli sample buffer containing 100 mM dithiothreitol (32) . For immunoprecipitation, lysates were cleared by centrifugation (13,000 ϫ g for 10 min at 4°C). Immunoprecipitations were performed by adding 0.4 g/ml of the appropriate antibody to the lysate and incubating with rotation at 4°C for 2 h. Pre-washed protein A-Sepharose or protein G-Sepharose, as appropriate, was added to the protein-antibody complex and incubated for a further 2 h. Immunoprecipitates were washed four times with 1 ml of lysis buffer. Proteins were eluted by boiling in Laemmli sample buffer containing 100 mM dithiothreitol and resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electrophoretically transferred onto nitrocellulose membranes and probed with appropriate antibodies. Immunoreactive proteins were visualized with a peroxidase-conjugated secondary antibody and a chemiluminescent detection system (33) . Bands on films were quantitated by scanning with an LKB Ultrascan densitometer. In experiments with untransfected human umbilical vein endothelial cells (HUVEC), confluent cells were placed in serum-free Medium 199 for 5 min before challenge with control vehicle or 10 ng/ml PMA for 30 min. Cells were then washed twice with PBS before cross-linking essentially as described previously (34, 35) . Briefly, cells were incubated at room temperature for 30 min in PBS containing 0.5 mM dithiobis(succinimidyl propionate) before quenching by the addition of 0.1 ml of 1 M Tris, pH 7.5, followed by two washes with ice-cold PBS. Cells were lysed and proteins immunoprecipitated as described above.
RESULTS
Phosphotyrosine Signaling through Tie-1 Is Impaired-Despite the importance of Tie-1 in blood vessel formation, the signaling pathways utilized by this receptor and its cellular functions are not known. To gain insight into Tie-1 signaling and function we used a chimeric receptor approach. cDNA was constructed in which the extracellular domain of Tie-1 was replaced with that of the nerve growth factor receptor TrkA. Endothelial cells were transfected with TrkA/Tie-1 chimeric receptors and 24 h later challenged with nerve growth factor (NGF) or control vehicle (Fig. 1) . The effects on tyrosine phosphorylation of cellular proteins were examined by anti-phosphotyrosine immunoblotting of whole cell lysates ( Fig. 1A ).
There was no detectable difference in the level of tyrosine phosphorylation or profile of phosphorylated proteins between control and NGF-treated cells. For comparison, parallel experiments were performed with cells transfected with chimeric receptors comprising the extracellular domain of TrkA and transmembrane and intracellular domains of Tie-2. A marked stimulation of tyrosine phosphorylation of several proteins, most notably those of approximately 135, 90, 72/70, 58, and 43 kDa, was seen following NGF treatment of TrkA/Tie-2-expressing endothelial cells. To examine phosphorylation status of the chimeric receptors, endothelial cells expressing TrkA/Tie-1 or TrkA/Tie-2 were challenged with NGF, lysed, and the receptors recovered by immunoprecipitation with antibodies against TrkA ectodomain. As shown in Fig. 1B TrkA/Tie-1 and TrkA/ Tie-2 were recovered from the respective cell lysates. TrkA/ Tie-2 was tyrosine-phosphorylated following NGF treatment of cells; however, TrkA/Tie-1 showed no evidence of tyrosine phosphorylation under control or NGF-stimulated conditions. These data suggest that Tie-1 is impaired in its ability to signal as a tyrosine kinase. To test this the intracellular domains of Tie-1 and Tie-2 were expressed in insect cells, and their kinase activity was measured. There was a significant difference between tyrosine kinase activity of Tie-1 and Tie-2 (Fig. 1C) . In contrast to Tie-2, Tie-1 exhibited no measurable tyrosine kinase activity above background (Fig. 1C) .
Tie-1 Physically Interacts with Tie-2-Other receptor tyrosine kinases reported to have negligible kinase activity include the heregulin receptor ErbB3 and an orphan receptor H-Ryk (36 -38) . In the case of ErbB3, ligand-induced heterodimerization of the receptor occurs with kinase-active members of the ErbB family, the most favorable interaction being with ErbB2 (39, 40) . This interaction activates phosphotyrosine signaling by ErbB2 and tyrosine phosphorylation of ErbB3, as well as stimulation of downstream pathways such as those involving extracellular signal-regulated kinase and c-Jun NH 2 -terminal kinase (41, 42) . We hypothesized that Tie-1 could initiate signaling if it were to become phosphorylated as a result of interaction with an active tyrosine kinase. The ability of Tie-1 to interact with Tie-2 was therefore tested. Endothelial cells were lysed and Tie-2 immunoprecipitated with an antibody specific for the Tie-2 ectodomain. Blots were probed for the presence of Tie-1. As shown in Fig. 2A , Tie-1 was co-immunoprecipitated with Tie-2 indicating that these two proteins were physically associated.
Tie-1 undergoes regulated endoproteolytic cleavage resulting in release of its extracellular domain and retention of a mem-brane-associated receptor fragment composed of the transmembrane and intracellular domains (31, 43, 44) . We therefore tested whether the endodomain alone could interact with Tie-2. Endothelial cells were treated with PMA which led to formation of the 45-kDa cell-associated Tie-1 endodomain as described previously (31, 43) . Tie-2 was immunoprecipitated from lysates of these cells using an antibody that recognizes the extracellular domain of Tie-2 (Fig. 2B ). Probing these immunoprecipitates with an antibody against the carboxyl-terminal sequence of the Tie-1 intracellular domain revealed Tie-1 endodomain co-immunoprecipitated with Tie-2 demonstrating association between the two proteins. These data also indicate that the motif responsible for association of the two receptors lies in their intracellular regions.
Involvement of the Tie-1 Tyrosine Kinase Domain in Binding of Tie-1 to Tie-2-The intracellular domain of Tie-1 consists of a transmembrane domain, juxtamembrane region, a tyrosine kinase domain, and a carboxyl-terminal tail sequence. Previously, it has been suggested that sequences within the ␣-helical transmembrane domains of some receptor tyrosine kinases mediate receptor dimerization (45) . We used deletion analysis to determine which regions of the endodomain mediate the interaction between Tie-1 and Tie-2. Forms of Tie-1 endodomain with amino-terminal FLAG epitope tags were constructed composed of the complete endodomain, transmembrane and juxtamembrane deleted, and carboxyl-terminal deleted endodomain (Fig. 3A) . These constructs were expressed in endothelial cells together with TrkA/Tie-2. Immunoprecipitations were performed with an antibody recognizing the epitope tag, and the recovered protein was probed for the presence of bound TrkA/Tie-2. As a control for nonspecific binding, a non-epitopetagged form of endodomain was expressed, and cell lysates were subjected to the same immunoprecipitation protocol. As shown in Fig. 3B , all FLAG-tagged endodomains were immunoprecipitated. Probing for the presence of TrkA/Tie-2 revealed complete endodomain, transmembrane, and juxtamembrane deleted and carboxyl-terminal deleted forms of Tie-1 all bound to TrkA/Tie-2. Nonspecific recovery of Tie-2 was minimal ( Fig. 3B) .
Activation of Tie-2 Does Not Induce Tyrosine Phosphorylation of Associated Tie-1-Tyrosine phosphorylation of kinasenegative receptors by active receptor tyrosine kinase partners within dimers or oligomers has been well documented (46 -49) . Indeed, transphosphorylation of an inactive receptor tyrosine kinase can augment the downstream effects of the active receptor (50) . It is therefore conceivable that phosphotyrosine-de-pendent signaling could be initiated from Tie-1 within the Tie-1⅐Tie-2 complex following unidirectional transphosphorylation by Tie-2. To examine this, Tie-1 holoreceptor was coexpressed with the chimeric TrkA/Tie-2 receptor in BAEC. Cells were stimulated by the addition of NGF and TrkA/Tie-2 immunoprecipitated with anti-TrkA antibody. As shown in Fig.  4A , NGF stimulated phosphorylation of TrkA/Tie-2. Probing blots for the presence of Tie-1 confirmed this receptor-bound Tie-2. However, there was no detectable tyrosine phosphorylation of Tie-1 bound to Tie-2 recovered from either unstimulated or stimulated cells. In further experiments TrkA/Tie-2 was co-expressed with a truncated form of Tie-1 corresponding to the endodomain. Again, the Tie-1 endodomain bound to Tie-2 was not tyrosine-phosphorylated under basal or stimulated conditions (Fig. 4B) . These data indicate that Tie-1 interaction with Tie-2 does not result in Tie-1 phosphorylation by the process of unidirectional transphosphorylation.
DISCUSSION
The orphan receptor Tie-1 is essential for vascular development where it appears to have roles in promoting vessel integrity and stability. In the present study we have begun to investigate the signaling mechanisms used by this receptor. One of the principal findings of this work was that Tie-1 exists as a pre-formed complex in endothelial cells with the related protein Tie-2. In addition, Tie-1 has negligible kinase activity and does not appear capable of inducing tyrosine phosphorylation of cellular proteins within endothelial cells. It is therefore unlikely that Tie-1 signals through the classical receptor tyrosine kinase mechanism of ligand-induced kinase activation via homo-oligomerization. It is possible that Tie-1 signaling could involve some phosphotyrosine-independent mechanism. Indeed, the orphan receptor tyrosine kinase H-Ryk is capable of activating downstream signaling cascades in the absence of any measurable effects on receptor phosphorylation. However, the physical association between Tie-1 and Tie-2 indicates that at least some aspects of signaling by these two receptors is intimately linked and strongly suggests that an important function of Tie-1 may be to modulate or contribute to Tie-2 signaling. By densitometric analysis of blots of immunoprecipitated and co-immunoprecipitated receptors to determine the fractions of complexed receptor, we estimate more than 80% of Tie-2 to exist in a complex with Tie-1. An extensive detailed analysis of relative distributions of the receptors between free and complexed forms, and the potential effects of agonists on this, is the subject of current investigations.
The finding that Tie-1 and Tie-2 exist as a pre-formed complex concurs with recent observations that have expanded the traditional view of receptor signaling to encompass the concept that receptor oligomerization can occur prior to ligand binding (51) . Receptors found to pre-assemble into complexes in the absence of ligand include members of the TNF receptor superfamily and the erythropoietin receptor (34, 52, 53) . In these cases, however, the complexes formed are homomeric. This contrasts with the current finding of heteromeric complexes between the related but distinct proteins Tie-1 and Tie-2. Ligand-independent association of members of the TNF receptor family has been shown to be mediated by a distinct motif, termed the pre-ligand binding assembly domain, present in the extracellular portion of the receptors (34) . Tie-1 binding to Tie-2 is mediated by the intracellular domains of the receptors. Deletion analysis demonstrated a 236-amino acid sequence between residues 825 and 1061 in Tie-1 harbors the domain responsible for binding Tie-2. Further studies are underway to resolve more precisely the residues involved.
The molecular basis for differences in kinase activity between Tie-1 and Tie-2 is not readily apparent. The kinase domains of the human Tie receptors share 84% amino acid sequence identity (7, 11) . In addition, all of the critically conserved amino acid residues in the protein kinase family (54) are present in Tie-1. One potential mechanism for initiating signaling from Tie-1 that would not require the receptor to have an active kinase would be through the creation of phosphotyrosine docking sites on Tie-1 by transphosphorylation following heterotypic interaction with an active receptor tyrosine kinase. A number of studies have demonstrated tyrosine phosphorylation of kinase-poor partners in heterodimeric-oligomeric complexes by more active component receptor tyrosine kinases (46 -49) . However, although Tie-1 and Tie-2 were found to associate, under the conditions examined here we did not observe tyrosine phosphorylation of Tie-1 under basal conditions or following activation of Tie-2 phosphorylation. Of course it is possible that certain conditions, such as binding of some known or unknown ligand to Tie-2 or Tie-1, could induce a change in the relative position or orientation of the receptors and permit such a transphosphorylation. The newly emerging theme that some receptors exist as pre-assembled complexes that bind and respond to ligand (34, 51) raises the intriguing possibility that a specific ligand may exist for the Tie-1⅐Tie-2 complex.
The inability to detect Tie-2 transphosphorylation of Tie-1 suggests the complex may have functions other than initiating signaling from Tie-1. Close comparison of the phenotypes of Tie-1-deficient and Tie-2-deficient mice has led to the conclusion that Tie-1 counteracts some of the effects of Tie-2 on microvascular development (4) . Furthermore, several previous reports have speculated that Tie-1 may be directly involved in regulating Tie-2 signaling (14, 22, 29) . The present finding of a physical interaction between the receptors strengthens this possibility and provides a number of potential mechanisms by which this could occur. The presence of Tie-1 bound to the intracellular domain of Tie-2 could, for example, restrict recruitment of signaling intermediates to phosphotyrosine docking sites in Tie-2 resulting in differences in the downstream signaling cascades initiated by activated Tie-2⅐Tie-1 and free Tie-2. In this regard it is interesting to note that the downstream effects of VEGF receptor-2 are altered when it undergoes ligand-induced heterodimerization with the relatively poor tyrosine kinase VEGF receptor-1 (55) . Further ways in which association with Tie-1 could influence Tie-2 signaling would include regulation of ligand accessibility or affinity for Tie-2. The fact that the extracellular domain of Tie-1 can be released in response to VEGF and TNF␣ (43, 44) , adds a further level of complexity to the potential regulatory influences that Tie-1 may exert over Tie-2.
